HELIX BIOPHARMA (HBP:TSE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trustmanic who wrote (34)	5/6/1997 2:13:00 PM
From: Jason Van Bergen	of 193

The important point to understand with regard to PharmaDerm' Dermal Drug Delivery Systems is that each product utilizing these systems will independently go through clinical trials. The success of the first products utilizing these systems will determine the potential for applying the Dermal Drug Delivery Systems to additional drugs, including drugs manufactured by other pharmaceutical companies. Already several of PharmaDerm's most advanced products are at various stages of clinical trials - we will be announcing milestones as they occur. As I mentioned in my last message, the first products utilizing the Dermal Drug Delivery Systems are generic pharmaceuticals, and are therefore expected to progress through the clinical trial process more quickly than novel pharmaceutical products.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next